Extranodal NK/T-cell Lymphoma, Nasal Type
1 competing product in clinical development for Extranodal NK/T-cell Lymphoma, Nasal Type.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Avastin + Gemcitabine + Oxaliplatin + Pegaspargase + Dexamethasone | Eli Lilly | Phase 2 | UNKNOWN | 52 |